V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008267 | 240005067 | 1.64 | null | null | 2014-04-10 | 2014-04-12 | CISPLATIN + VINORELBINE | N | Y | 240006002 | CTD |
| 240008268 | 240005068 | 1.74 | null | Curative (C) | 2017-06-25 | 2017-07-01 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 240006158 | AML18 TRIAL |
| 240008269 | 240005068 | 1.56 | 62.4 | Disease modification (D) | 2016-08-04 | 2016-08-06 | CARBOPLATIN + RT | N | N | 240006158 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240008270 | 240005068 | 1.73 | 13.2 | Curative (C) | null | 2018-06-13 | LENALIDOMIDE | null | Y | 240006158 | PCV |
| 240008271 | 240005069 | 1.75 | 95 | null | null | 2015-07-11 | CYCLOPHOSPHAMIDE | null | Y | 240006303 | AML19 TRIAL |
| 240008272 | 240005070 | 1.65 | 54.6 | Curative (C) | 2014-01-02 | 2014-01-03 | CRIZOTINIB | 2 | N | 240006338 | CISPLATIN + PACLITAXEL |
| 240008273 | 240010803 | 1.67 | 0 | Palliative (P) | 2018-02-20 | 2018-02-20 | AML18 PILOT TRIAL | 2 | N | 240006341 | CAV |
| 240008274 | 240005071 | 1.55 | 77.8 | Curative (C) | 2018-10-06 | 2018-10-06 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 240006367 | DOXORUBICIN |
| 240008275 | 240005071 | 1.62 | 84 | Palliative (P) | 2015-02-02 | 2015-02-05 | IVA | N | N | 240006367 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008276 | 240005072 | 1.67 | 73.3 | Palliative (P) | 2017-04-10 | 2017-04-18 | Cytarabine Low Dose | 02 | N | 240006388 | CVP |
| 240008277 | 240005073 | 1.67 | 0 | Curative (C) | 2014-08-10 | 2014-08-17 | CARBOPLATIN + RT | 2 | N | 240006436 | CISPLATIN + TOPOTECAN |
| 240008280 | 240005074 | 1.91 | 81.5 | null | 2017-06-05 | 2017-06-19 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 240006577 | OEPA |
| 240008281 | 240005075 | 1.59 | 70.1 | Palliative (P) | 2018-04-23 | 2018-04-30 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 240006607 | FLUDARABINE |
| 240008282 | 240005076 | 1.85 | null | Disease modification (D) | 2018-12-28 | 2019-01-01 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | Y | N | 240006614 | CLOFARABINE + CYTARABINE |
| 240008283 | 240005076 | 1.85 | 0 | Curative (C) | 2016-04-14 | 2016-04-19 | Triple Intrathecal | 02 | N | 240006614 | R CODOX M |
| 240008284 | 240005077 | 1.64 | null | Adjuvant (A) | 2017-04-01 | 2017-04-05 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 240006754 | CISPLATIN + ETOPOSIDE |
| 240008285 | 240005078 | 1.58 | 72 | Adjuvant (A) | 2017-04-03 | 2017-04-12 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | 240006831 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 240008286 | 240005078 | 1.54 | 77 | null | 2014-10-24 | 2014-10-31 | CTD Attenuated (Thalidomide 50mg) | null | N | 240006831 | ESHAP R |
| 240008288 | 240005080 | null | null | Curative (C) | 2016-12-28 | 2017-01-03 | BORTEZOMIB + THALIDOMIDE | 02 | N | 240006976 | FLAG + IDARUBICIN |
| 240008289 | 240005080 | null | 86 | Curative (C) | 2015-02-17 | 2015-02-17 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 240006976 | ECX |
| 240008290 | 240005081 | 1.66 | 71 | null | 2017-04-13 | 2017-04-15 | IDARAM | 01 | N | 240007054 | CARBOPLATIN + PEMETREXED |
| 240008291 | 240005081 | 1.71 | 58.5 | Disease modification (D) | 2017-08-07 | 2017-08-08 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 240007054 | BEAM |
| 240008292 | 240005082 | 1.53 | 95 | Curative (C) | 2016-02-12 | 2016-02-15 | Thalidomide 100mg | N | N | 240007170 | CYTARABINE |
| 240008293 | 240005083 | 1.53 | null | Curative (C) | 2017-01-31 | 2017-03-12 | DA-EPOCH-R | null | N | 240007176 | R-EPOCH |
| 240008294 | 240005084 | 1.74 | 63.5 | Curative (C) | 2017-04-26 | 2017-04-26 | IDARAM | N | N | 240007193 | CYTARABINE HD + METHOTREXATE HD |
| 240008295 | 240005085 | 1.58 | null | Palliative (P) | 2017-01-28 | 2017-01-17 | Lenalidomide 10mg (Cycle 1 to 25) | N | N | 240007252 | CHLVPP |
| 240008296 | 240010810 | 1.7 | 73 | Curative (C) | 2014-08-27 | 2014-08-27 | IMMUNOGLOBULIN | null | N | 240007254 | CLADRIBINE |
| 240008297 | 240005086 | 1.74 | 81 | Palliative (P) | 2017-05-22 | 2017-05-29 | Y-90 | 02 | N | 240007268 | IDARUBICIN |
| 240008298 | 240005086 | 1.75 | null | Neo-adjuvant (N) | 2017-07-04 | 2017-07-04 | Bortezomib (weekly) | Y | null | 240007268 | METHOTREXATE HIGH DOSE |
| 240008299 | 240005087 | 1.78 | null | Curative (C) | 2017-11-20 | 2017-11-20 | ICE-R | N | N | 240007284 | CVP |
| 240008300 | 240005088 | 1.71 | 60.4 | Curative (C) | 2017-04-13 | 2017-04-14 | Gemcitabine + Capecitabine | 2 | N | 240007327 | CYTARABINE |
| 240008301 | 240005089 | 0 | 80 | Curative (C) | 2017-01-31 | 2017-02-06 | GDP | N | N | 240007333 | FCR |
| 240008302 | 240005090 | 1.65 | 67.5 | Palliative (P) | 2014-12-14 | 2014-12-13 | Capecitabine (21days) + Carboplatin | N | N | 240007353 | ETOPOSIDE |
| 240008303 | 240005091 | 1.58 | 47.6 | Curative (C) | 2014-12-12 | 2014-12-14 | PACLITAXEL | 2 | N | 240007369 | BEVACIZUMAB |
| 240008304 | 240005092 | 1.56 | 60.2 | null | 2016-08-14 | 2016-08-28 | Paclitaxel 7 day | N | null | 240007399 | TEMOZOLOMIDE |
| 240008305 | 240010812 | null | null | Curative (C) | 2015-12-20 | 2015-12-20 | FLUOROURACIL + OXALIPLATIN | N | N | 240007447 | CARBOPLATIN + RT |
| 240008306 | 240005093 | 1.5 | 54.4 | Curative (C) | 2015-01-21 | 2015-01-23 | Temozolomide + RT | N | N | 240007448 | ABVD |
| 240008309 | 240005095 | 1.66 | 55 | Palliative (P) | 2018-07-15 | 2018-07-19 | Cisplatin + Etoposide (3 day) | N | N | 240007531 | ESHAP R |
| 240008310 | 240005095 | 1.55 | 65.8 | null | 2016-08-20 | 2016-08-20 | CYCLOPHOSPHAMIDE + DEXAMETHASONE | 02 | N | 240007531 | GEMCITABINE |
| 240008311 | 240005096 | 1.53 | 79 | Curative (C) | null | 2013-08-27 | Cisplatin + Topotecan | N | null | 240007570 | CAPECITABINE + OXALIPLATIN |
| 240008312 | 240010815 | 1.67 | 102 | Curative (C) | 2017-01-29 | 2017-02-11 | CVP | 02 | N | 240007585 | NORDIC |
| 240008313 | 240010815 | 1.56 | 76 | Curative (C) | 2017-02-10 | 2017-02-24 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 240007585 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240008314 | 240005097 | 1.69 | 55.8 | Disease modification (D) | 2018-06-05 | 2018-07-01 | IVA | N | Y | 240007751 | CISPLATIN + FLUOROURACIL + RT |
| 240008315 | 240005097 | 1.66 | 78.6 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-10 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240007751 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 240008316 | 240005098 | 1.83 | 82 | Disease modification (D) | 2017-09-01 | 2017-09-02 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | N | 240007811 | BUSULPHAN |
| 240008317 | 240010817 | 1.62 | null | Curative (C) | 2017-05-20 | 2017-05-28 | CISPLATIN + FLUOROURACIL + RT | N | N | 240007869 | CISPLATIN + VINORELBINE |
| 240008318 | 240010817 | 1.69 | 61 | Palliative (P) | 2016-10-11 | 2016-10-19 | PEMBROLIZUMAB | N | null | 240007869 | CAPECITABINE + OXALIPLATIN |
| 240008319 | 240005099 | 1.76 | null | Disease modification (D) | null | 2017-11-28 | Cisplatin + Etoposide (3 day) | null | null | 240007918 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008320 | 240005099 | 1.48 | 69.3 | Curative (C) | 2017-01-21 | 2017-01-24 | FLAG + Idarubicin | 02 | Y | 240007918 | CISPLATIN + ETOPOSIDE |
| 240008321 | 240005100 | 1.52 | null | Not known (9) | 2017-05-27 | 2017-06-12 | Cisplatin + Topotecan | N | N | 240007970 | IPILIMUMAB |